This drug has demonstrated great potential in improving the clinical outcomes of patients with type 2 diabetes
Aunque ambos contienen semaglutida, Ozempic est aprobado para diabetes tipo 2 con dosis hasta 2 mg semanales, mientras que Wegovy est indicado para manejo del peso con dosis hasta 2.4 mg semanales
Otterbein LEBFH, Alam J, Soares M, Tao Lu H, Wysk M, Davis RJ, Flavell RA, Choi AM: Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway
Who May See Less Dramatic Results Some patients may see more modest improvement in insulin resistance: Advanced Type 2 diabetes: Patients with long-standing diabetes and significant beta cell dysfunction may have less capacity to benefit from improved insulin sensitivity
This measured approach means your price stays flat while your dose optimizes to your individual tolerance